Earlier today, Lunda-based Respiratorius published its fourth quarter report and the company is now facing an eventful year with the main projects VAL001 and RESP9000. Respiratorius CEO Johan Drott visited BioStock's studio to talk more about the activities in the ongoing projects, the patent situation and the investments being made to accelerate the development work.
Watch the interview with Respirator vd Johan Drott below.
The content of BioStock's news and analysis is independent, but BioStock's operations are to some extent financed by companies in the industry. This post refers to a company from which BioStock has received funding.